| 13 | $GMGI 0.0009 -0.0004 -30.77% 3,497,574 Chart, | mick | 03/31/2017 3:46:25 PM |
| 11 | $SRGL news is out: Source Gold Corp. Provides | Stock Diva | 11/20/2015 9:24:55 AM |
| 10 | SRGL 0.0001 Real-Time Bid & Ask 0.0001 / | leahanne | 08/04/2014 9:52:10 PM |
| 9 | SRGL Stock Charts Friday, August 1, 2014 9:28:14 | chartguy89 | 08/01/2014 9:28:16 PM |
| 8 | SRGL News Friday, August 1, 2014 9:25:29 PM $SRGL | Stock_Tracker | 08/01/2014 9:25:31 PM |
| 7 | SRGL Financials 07/16/2014 00:41:30 Source Gold | Emylers | 07/16/2014 1:41:27 AM |
| 6 | 6 Filings posted in last 30 days SRGL OTCQB LAST | Vikingzskillz | 04/12/2014 8:31:30 AM |
| 5 | Source Gold Corp Files SC 13G $$SRGL$$ | Vikingzskillz | 04/12/2014 8:23:12 AM |
| 4 | Latest Source Gold Corp. (SRGL) Headlines 10-Q: | Stock_Tracker | 03/11/2014 11:56:09 AM |
| 3 | SRGL 0.0007 Stock Charts $SRGL 1 Month Chart | chartguy89 | 03/10/2014 12:23:23 AM |
| 2 | SRGL Stock Charts Last: +0.0002 Saturday, March | chartguy89 | 03/01/2014 7:04:43 PM |
| 1 | SRGL News Source Gold Corp. Negotiating | lucyinthesky | 10/08/2012 9:25:22 AM |
Recent Articles
- How to Find the Perfect New Home in Your Desired Location
- Discover RubyReels: Australia’s Next Top Online Casino in 2025
- DeLeion Capital Seizes Opportunities in Crypto Landscape
- EU Takes Bold Steps to Secure Rare Earth Supply Chain
- What Investors Need to Know About Jasper Therapeutics Class Action
- KBR Investors Urged to Act Ahead of Class Action Deadline
- Trump's Rally in New Jersey: A Clash of Political Titans
- Discover the Excellence of Kratom Bird's Online Shopping Experience
- Avacta Unveils Promising Dual Payload Data from Cancer Therapies
- Exploring the Breakthrough Potential of BBO-10203 in Cancer Treatment
- AlphaTON Capital and Cyncado Therapeutics Advance Cancer Research
- Investor Insights: Key Stocks Sparking Discussions This Week
- Novartis Unveils Promising Results in Autoimmune Research
- Innovative CLN-978 Shows Promise for Autoimmune Treatments
- Innovative Advances in Rare Disease Care Highlighted by Sobi
- Cytokinetics Faces Class Action: What Investors Need to Know
- Innovative B Cell Treatment CLN-978 Shows Promising Data
- Exploring Elon Musk's Vision for a Future with Universal High Income
- The Digital Hotelier's Bold Move into the Americas Market
- BIMZELX® Insights: Three-Year Results in Rheumatology Showcase Progress
- Innovative CAR-Treg Therapy QEL-005 Set for Major Reveal
- KYV-101: A Promising New Therapy Option for Rheumatoid Arthritis
- Sify Technologies Delivers Strong Quarter with Robust Growth Metrics
- Sify Technologies Q2 FY 2025-26 Results: Growth Insights
- Quantum Corporation Class Action: Key Updates and Next Steps
- MoonBull ($MOBU) Achieves Presale Milestone and Engages Community
- Understanding Investor Rights: Telix Pharmaceuticals Class Action Details
- Unveiling Taiwan's Historical Legacy Through a Personal Journey
- Unlocking America's Hidden Mineral Wealth and Its Impact
- Phathom Pharmaceuticals' VOQUEZNA® Shows Promising GERD Relief
- Invest in Your Future: Class Action Details on V.F. Corp
- LiTime Unveils Innovative Lithium Solutions for Landscaping
- Grant Cardone Explores Future of Investments in Bitcoin and Real Estate
- MOVA Launches Innovative Smart Outdoor Tech at Equip Exposition
- Discover How MENU – ORDER AI is Transforming Healthy Dining
- Mutuum Finance Gears Up for V1 Protocol Launch: What to Expect
- Stock Movements: Beyond Meat, Intel, and Newmont's Earnings Impact
- Unlocking Vehicle Security with the LAMTTO DC22 Dash Camera
- Mutuum Finance Excels with Significant Funding as It Prepares for V1 Launch
- Uniting Hearts and Homes: A Mission to Save Pets in Miami
- Reviving Taiwan's History: A Journey Through Time and Sacrifice
- How a Heist Sparked a Creative Marketing Campaign for Böcker
- Exciting Week in Crypto: Insights from Coinbase and Market Movements
- Deepinder Goyal's $25 Million Vision for Human Longevity
- Impact of Trump Policies on Pennsylvania's Trade with Canada
- Concerns Rise Over Tesla's Future as BYD Outpaces Competition
- Revolutionary Phase 3 Trial Data Shows Promise for ITM-11
- Major Changes at X: Advertising Chief Nitti Departs Company
- Cardiovalve Targets CE Mark for Advanced Heart Valve Solutions
- Milestone Achieved: Cardiovalve Completes TARGET Study Enrollment
